Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Iwona
Iwona Blasinska, Poznan PL
| Patent application number | Description | Published |
|---|---|---|
| 20100255173 | INSTANT NOODLES - The instant noodles, containing flour or a mix of flours and possibly salt, include from 0.5 to 3.0 weight percent of the dietary fibre preparation, that has the fibres of the maximal length 400 micrometers, favorably to 250 micrometers, but at the same time about 90% percent of the fibres are of length under 120 micrometers. | 10-07-2010 |
Iwona Fijalkowska, Rockville, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20090258834 | Plasma protein-binding ligands - The invention provides an isolated or purified peptide that binds at least one plasma protein. In one embodiment, the isolated or purified peptide binds to fibrinogen, comprises no more than 10 amino acids, and comprises an amino acid sequence Xaa | 10-15-2009 |
Iwona Gawronska, Poznan PL
| Patent application number | Description | Published |
|---|---|---|
| 20100076053 | SEQUENCE OF DSRNA: ATN-RNA, INTERVENTION USING IRNAI, USE OF A SEQUENCE OF DSRNA: ATN-RNA, A METHOD OF TREATING AND INHIBITING A BRAIN TUMOR, A KIT FOR INHIBITING CANCER CELL WHICH EXPRESSES TENASCIN, A METHOD FOR A KIT PREPARATION IN A BRAIN TUMOR THERAPY - The subject matters of this invention are a sequence of double-stranded RNA: ATN-RNA, intervention using interference RNA (iRNAi), use of a sequence of double-stranded RNA: ATN-RNA, a method of treating a brain tumor and a method of inhibiting a brain tumor cells which express tenascin, a kit for inhibiting cancer cell which expresses tenascin and a method for a kit preparation in a brain tumor therapy. Malignant gliomas preferentially express a number of surface markers that may be exploited as therapeutic targets, including tenascin-C, an extracellular matrix glycoprotein that is ubiquitously expressed by malignant gliomas and probably contributes to tumor cell adhesion, invasion, migration and proliferation. For tenascin-C inhibition, RNA interference intervention (iRNAi) approach have been applied. | 03-25-2010 |
Iwona Sokolowska, Warszawa PL
| Patent application number | Description | Published |
|---|---|---|
| 20110136736 | NEW INSULIN ANALOGUES OF PROLONGED ACTIVITY - New biosynthetic analogues of recombined human insulin of prolonged therapeutical activity, which can find place in prophylactic and treatment of diabetes. | 06-09-2011 |
Iwona Turlik, Barrington, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20080255996 | System and Method for Exchanging Assets in a Network - A first negotiation ( | 10-16-2008 |
Iwona Yike, Chardon, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20080199882 | METHOD FOR DETECTION OF BIOMARKERS FOR EXPOSURE TO STACHYBOTRYS - A method of determining exposure of an individual to a macrocyclic trichothecene comprises isolating a sample of at least a portion of a naturally occurring protein from an individual, and detecting a reaction of the sample with a macrocyclic trichothecene. The macrocyclic trichothecene may be a product of | 08-21-2008 |